Optimal Gossip in Store-and-Forward Noncombining 2-D Tori

M. Soch,P. Tvrdík

DOI: https://doi.org/10.1007/BFb0002738

1997-08-26

Abstract:

What problem does this paper attempt to address?

Long COVID manifests with T cell dysregulation, inflammation, and an uncoordinated adaptive immune response to SARS-CoV-2

Kailin Yin,Michael J Peluso,Xiaoyu Luo,Reuben Thomas,Min-Gyoung Shin,Jason Neidleman,Alicer Andrew,Kyrlia Young,Tongcui Ma,Rebecca Hoh,Khamal Anglin,Beatrice Huang,Urania Argueta,Monica Lopez,Daisy Valdivieso,Kofi Asare,Tyler-Marie Deveau,Sadie E Munter,Rania Ibrahim,Ludger Ständker,Scott Lu,Sarah A Goldberg,Sulggi A Lee,Kara L Lynch,J Daniel Kelly,Jeffrey N Martin,Jan Münch,Steven G Deeks,Timothy J Henrich,Nadia R Roan

DOI: https://doi.org/10.1101/2023.02.09.527892

2023-08-04

bioRxiv

Abstract:Long COVID (LC), a type of post-acute sequelae of SARS-CoV-2 infection (PASC), occurs after at least 10% of SARS-CoV-2 infections, yet its etiology remains poorly understood. Here, we used multiple "omics" assays (CyTOF, RNAseq/scRNAseq, Olink) and serology to deeply characterize both global and SARS-CoV-2-specific immunity from blood of individuals with clear LC and non-LC clinical trajectories, 8 months following infection and prior to receipt of any SARS-CoV-2 vaccine. Our analysis focused on deep phenotyping of T cells, which play important roles in immunity against SARS-CoV-2 yet may also contribute to COVID-19 pathogenesis. Our findings demonstrate that individuals with LC exhibit systemic inflammation and immune dysregulation. This is evidenced by global differences in T cell subset distribution in ways that imply ongoing immune responses, as well as by sex-specific perturbations in cytolytic subsets. Individuals with LC harbored increased frequencies of CD4+ T cells poised to migrate to inflamed tissues, and exhausted SARS-CoV-2-specific CD8+ T cells. They also harbored significantly higher levels of SARS-CoV-2 antibodies, and in contrast to non-LC individuals, exhibited a mis-coordination between their SARS-CoV-2-specific T and B cell responses. RNAseq/scRNAseq and Olink analyses similarly revealed immune dysregulatory mechanisms, along with non-immune associated perturbations, in individuals with LC. Collectively, our data suggest that proper crosstalk between the humoral and cellular arms of adaptive immunity has broken down in LC, and that this, perhaps in the context of persistent virus, leads to the immune dysregulation, inflammation, and clinical symptoms associated with this debilitating condition.
Long COVID manifests with T cell dysregulation, inflammation and an uncoordinated adaptive immune response to SARS-CoV-2

Kailin Yin,Michael J. Peluso,Xiaoyu Luo,Reuben Thomas,Min-Gyoung Shin,Jason Neidleman,Alicer Andrew,Kyrlia C. Young,Tongcui Ma,Rebecca Hoh,Khamal Anglin,Beatrice Huang,Urania Argueta,Monica Lopez,Daisy Valdivieso,Kofi Asare,Tyler-Marie Deveau,Sadie E. Munter,Rania Ibrahim,Ludger Ständker,Scott Lu,Sarah A. Goldberg,Sulggi A. Lee,Kara L. Lynch,J. Daniel Kelly,Jeffrey N. Martin,Jan Münch,Steven G. Deeks,Timothy J. Henrich,Nadia R. Roan

DOI: https://doi.org/10.1038/s41590-023-01724-6

IF: 30.5

2024-01-12

Nature Immunology

Abstract:Long COVID (LC) occurs after at least 10% of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections, yet its etiology remains poorly understood. We used 'omic" assays and serology to deeply characterize the global and SARS-CoV-2-specific immunity in the blood of individuals with clear LC and non-LC clinical trajectories, 8 months postinfection. We found that LC individuals exhibited systemic inflammation and immune dysregulation. This was evidenced by global differences in T cell subset distribution implying ongoing immune responses, as well as by sex-specific perturbations in cytolytic subsets. LC individuals displayed increased frequencies of CD4 + T cells poised to migrate to inflamed tissues and exhausted SARS-CoV-2-specific CD8 + T cells, higher levels of SARS-CoV-2 antibodies and a mis-coordination between their SARS-CoV-2-specific T and B cell responses. Our analysis suggested an improper crosstalk between the cellular and humoral adaptive immunity in LC, which can lead to immune dysregulation, inflammation and clinical symptoms associated with this debilitating condition.

immunology
Distinguishing features of Long COVID identified through immune profiling

Jon Klein,Jamie Wood,Jillian Jaycox,Rahul M. Dhodapkar,Peiwen Lu,Jeff R. Gehlhausen,Alexandra Tabachnikova,Kerrie Greene,Laura Tabacof,Amyn A. Malik,Valter Silva Monteiro,Julio Silva,Kathy Kamath,Minlu Zhang,Abhilash Dhal,Isabel M. Ott,Gabrielee Valle,Mario Peña-Hernandez,Tianyang Mao,Bornali Bhattacharjee,Takehiro Takahashi,Carolina Lucas,Eric Song,Dayna Mccarthy,Erica Breyman,Jenna Tosto-Mancuso,Yile Dai,Emily Perotti,Koray Akduman,Tiffany J. Tzeng,Lan Xu,Anna C. Geraghty,Michelle Monje,Inci Yildirim,John Shon,Ruslan Medzhitov,Denyse Lutchmansingh,Jennifer D. Possick,Naftali Kaminski,Saad B. Omer,Harlan M. Krumholz,Leying Guan,Charles S. Dela Cruz,David van Dijk,Aaron M. Ring,David Putrino,Akiko Iwasaki

DOI: https://doi.org/10.1038/s41586-023-06651-y

IF: 64.8

2023-09-26

Nature

Abstract:Post-acute infection syndromes (PAIS) may develop after acute viral disease 1 . Infection with SARS-CoV-2 can result in the development of a PAIS known as "Long COVID" (LC). Individuals with LC frequently report unremitting fatigue, post-exertional malaise, and a variety of cognitive and autonomic dysfunctions 2–4 ; however, the biological processes associated with the development and persistence of these symptoms are unclear. Here, 273 individuals with or without LC were enrolled in a cross-sectional study that included multi-dimensional immune phenotyping and unbiased machine learning methods to identify biological features associated with LC. Marked differences were noted in circulating myeloid and lymphocyte populations relative to matched controls, as well as evidence of exaggerated humoral responses directed against SARS-CoV-2 among participants with LC. Further, higher antibody responses directed against non-SARS-CoV-2 viral pathogens were observed among individuals with LC, particularly Epstein-Barr virus. Levels of soluble immune mediators and hormones varied among groups, with cortisol levels being lower among participants with LC. Integration of immune phenotyping data into unbiased machine learning models identified key features most strongly associated with LC status. Collectively, these findings may help guide future studies into the pathobiology of LC and aid in developing relevant biomarkers.

multidisciplinary sciences
The effect of bending radius on V-I characteristics of mono- and multicored BiPb-2223 tapes with and without Ag additions

I. Akimov,E. V. Antipova,S.N. Barabanov,N. Kozlenkova,P. Kuznetsov,A. Nikulin,D. N. Rakov,A. Shikov,N. Khlebova,D.A. Filitchev

DOI: https://doi.org/10.1109/77.620769

IF: 1.9489

1997-06-01

IEEE Transactions on Applied Superconductivity

Abstract:The effect of bending strain on Voltage-Current Characteristics (VCC) of BiPbSrCaCuO-2223/(Ag and Ag-alloy sheathed) tapes with and without Ag additions into the core have been studied. The testing probe allows us to carry out all set of bending tests up to radius 5 mm on the same specimen. The critical current Ic and shape of high-sensitivity VCC as a function of bending strain are analysed. Degradation of current carrying capacity under bending deformation is caused by the formation of microcracks. The overlapping of microcracks in Bi-2223/Ag sheathed tapes without Ag additions leads to current overflow into the Ag sheath and to appearance of linear resistance segment in the V-I curve at low electric field.
The Central Role of Low-Grade Inflammation and Multisystem Involvement

Evgenii Gusev,Alexey Sarapultsev

DOI: https://doi.org/10.3390/ijms25126389

IF: 5.6

2024-06-10

International Journal of Molecular Sciences

Abstract:Long COVID (LC), also referred to as Post COVID-19 Condition, Post-Acute Sequelae of SARS-CoV-2 Infection (PASC), and other terms, represents a complex multisystem disease persisting after the acute phase of COVID-19. Characterized by a myriad of symptoms across different organ systems, LC presents significant diagnostic and management challenges. Central to the disorder is the role of low-grade inflammation, a non-classical inflammatory response that contributes to the chronicity and diversity of symptoms observed. This review explores the pathophysiological underpinnings of LC, emphasizing the importance of low-grade inflammation as a core component. By delineating the pathogenetic relationships and clinical manifestations of LC, this article highlights the necessity for an integrated approach that employs both personalized medicine and standardized protocols aimed at mitigating long-term consequences. The insights gained not only enhance our understanding of LC but also inform the development of therapeutic strategies that could be applicable to other chronic conditions with similar pathophysiological features.

biochemistry & molecular biology,chemistry, multidisciplinary
A Mixed Method Systematic Review

Nawar Diar Bakerly,Nikki Smith,Julie L. Darbyshire,Joseph Kwon,Emily Bullock,Sareeta Baley,Manoj Sivan,Brendan Delaney

DOI: https://doi.org/10.3390/ijerph21040473

IF: 4.614

2024-04-13

International Journal of Environmental Research and Public Health

Abstract:Introduction: Long COVID (LC) is a global public health crisis affecting more than 70 million people. There is emerging evidence of different pathophysiological mechanisms driving the wide array of symptoms in LC. Understanding the relationships between mechanisms and symptoms helps in guiding clinical management and identifying potential treatment targets. Methods: This was a mixed-methods systematic review with two stages: Stage one (Review 1) included only existing systematic reviews (meta-review) and Stage two (Review 2) was a review of all primary studies. The search strategy involved Medline, Embase, Emcare, and CINAHL databases to identify studies that described symptoms and pathophysiological mechanisms with statistical analysis and/or discussion of plausible causal relationships between mechanisms and symptoms. Only studies that included a control arm for comparison were included. Studies were assessed for quality using the National Heart, Lung, and Blood Institute quality assessment tools. Results: 19 systematic reviews were included in Review 1 and 46 primary studies in Review 2. Overall, the quality of reporting across the studies included in this second review was moderate to poor. The pathophysiological mechanisms with strong evidence were immune system dysregulation, cerebral hypoperfusion, and impaired gas transfer in the lungs. Other mechanisms with moderate to weak evidence were endothelial damage and hypercoagulation, mast cell activation, and auto-immunity to vascular receptors. Conclusions: LC is a complex condition affecting multiple organs with diverse clinical presentations (or traits) underpinned by multiple pathophysiological mechanisms. A 'treatable trait' approach may help identify certain groups and target specific interventions. Future research must include understanding the response to intervention based on these mechanism-based traits.

public, environmental & occupational health,environmental sciences
Pathophysiological, immunological, and inflammatory features of long COVID

Karen Bohmwald,Benjamín Diethelm-Varela,Linmar Rodríguez-Guilarte,Thomas Rivera,Claudia A. Riedel,Pablo A. González,Alexis M. Kalergis

DOI: https://doi.org/10.3389/fimmu.2024.1341600

IF: 7.3

2024-02-29

Frontiers in Immunology

Abstract:The COVID-19 pandemic continues to cause severe global disruption, resulting in significant excess mortality, overwhelming healthcare systems, and imposing substantial social and economic burdens on nations. While most of the attention and therapeutic efforts have concentrated on the acute phase of the disease, a notable proportion of survivors experience persistent symptoms post-infection clearance. This diverse set of symptoms, loosely categorized as long COVID, presents a potential additional public health crisis. It is estimated that 1 in 5 COVID-19 survivors exhibit clinical manifestations consistent with long COVID. Despite this prevalence, the mechanisms and pathophysiology of long COVID remain poorly understood. Alarmingly, evidence suggests that a significant proportion of cases within this clinical condition develop debilitating or disabling symptoms. Hence, urgent priority should be given to further studies on this condition to equip global public health systems for its management. This review provides an overview of available information on this emerging clinical condition, focusing on the affected individuals' epidemiology, pathophysiological mechanisms, and immunological and inflammatory profiles.

immunology
Immune Mechanisms Underpinning Long COVID: Collegium Internationale Allergologicum Update 2024

Eva Untersmayr,Carina Venter,Peter Smith,Johanna Rohrhofer,Cebile Ndwandwe,Jurgen Schwarze,Emer Shannon,Milena Sokolowska,Corinna Sadlier,Liam O'Mahony,Liam O’Mahony

DOI: https://doi.org/10.1159/000535736

2024-01-22

International Archives of Allergy and Immunology

Abstract:Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can result in a prolonged multisystem disorder termed long COVID, which may affect up to 10% of people following coronavirus disease 2019 (COVID-19). It is currently unclear why certain individuals do not fully recover following SARS-CoV-2 infection. Summary: In this review, we examine immunological mechanisms that may underpin the pathophysiology of long COVID. These mechanisms include an inappropriate immune response to acute SARS-CoV-2 infection, immune cell exhaustion, immune cell metabolic reprogramming, a persistent SARS-CoV-2 reservoir, reactivation of other viruses, inflammatory responses impacting the central nervous system, autoimmunity, microbiome dysbiosis, and dietary factors. Key Messages: Unfortunately, the currently available diagnostic and treatment options for long COVID are inadequate, and more clinical trials are needed that match experimental interventions to underlying immunological mechanisms.

immunology,allergy
A review of cytokine-based pathophysiology of Long COVID symptoms

Russell N. Low,Ryan J. Low,Athena Akrami

DOI: https://doi.org/10.3389/fmed.2023.1011936

IF: 3.9

2023-03-31

Frontiers in Medicine

Abstract:The Long COVID/Post Acute Sequelae of COVID-19 (PASC) group includes patients with initial mild-to-moderate symptoms during the acute phase of the illness, in whom recovery is prolonged, or new symptoms are developed over months. Here, we propose a description of the pathophysiology of the Long COVID presentation based on inflammatory cytokine cascades and the p38 MAP kinase signaling pathways that regulate cytokine production. In this model, the SARS-CoV-2 viral infection is hypothesized to trigger a dysregulated peripheral immune system activation with subsequent cytokine release. Chronic low-grade inflammation leads to dysregulated brain microglia with an exaggerated release of central cytokines, producing neuroinflammation. Immunothrombosis linked to chronic inflammation with microclot formation leads to decreased tissue perfusion and ischemia. Intermittent fatigue, Post Exertional Malaise (PEM), CNS symptoms with “brain fog,” arthralgias, paresthesias, dysautonomia, and GI and ophthalmic problems can consequently arise as result of the elevated peripheral and central cytokines. There are abundant similarities between symptoms in Long COVID and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). DNA polymorphisms and viral-induced epigenetic changes to cytokine gene expression may lead to chronic inflammation in Long COVID patients, predisposing some to develop autoimmunity, which may be the gateway to ME/CFS.

medicine, general & internal
Metabolomic and immune alterations in long COVID patients with chronic fatigue syndrome

Suguru Saito,Shima Shahbaz,Xian Luo,Mohammed Osman,Desiree Redmond,Jan Willem Cohen Tervaert,Liang Li,Shokrollah Elahi

DOI: https://doi.org/10.3389/fimmu.2024.1341843

IF: 7.3

2024-01-18

Frontiers in Immunology

Abstract:Introduction: A group of SARS-CoV-2 infected individuals present lingering symptoms, defined as long COVID (LC), that may last months or years post the onset of acute disease. A portion of LC patients have symptoms similar to myalgic encephalomyelitis or chronic fatigue syndrome (ME/CFS), which results in a substantial reduction in their quality of life. A better understanding of the pathophysiology of LC, in particular, ME/CFS is urgently needed. Methods: We identified and studied metabolites and soluble biomarkers in plasma from LC individuals mainly exhibiting ME/CFS compared to age-sex-matched recovered individuals (R) without LC, acute COVID-19 patients (A), and to SARS-CoV-2 unexposed healthy individuals (HC). Results: Through these analyses, we identified alterations in several metabolomic pathways in LC vs other groups. Plasma metabolomics analysis showed that LC differed from the R and HC groups. Of note, the R group also exhibited a different metabolomic profile than HC. Moreover, we observed a significant elevation in the plasma pro-inflammatory biomarkers (e.g. IL-1α, IL-6, TNF-α, Flt-1, and sCD14) but the reduction in ATP in LC patients. Our results demonstrate that LC patients exhibit persistent metabolomic abnormalities 12 months after the acute COVID-19 disease. Of note, such metabolomic alterations can be observed in the R group 12 months after the acute disease. Hence, the metabolomic recovery period for infected individuals with SARS-CoV-2 might be long-lasting. In particular, we found a significant reduction in sarcosine and serine concentrations in LC patients, which was inversely correlated with depression, anxiety, and cognitive dysfunction scores. Conclusion: Our study findings provide a comprehensive metabolomic knowledge base and other soluble biomarkers for a better understanding of the pathophysiology of LC and suggests sarcosine and serine supplementations might have potential therapeutic implications in LC patients. Finally, our study reveals that LC disproportionally affects females more than males, as evidenced by nearly 70% of our LC patients being female.

immunology
Pathogenesis Underlying Neurological Manifestations of Long COVID Syndrome and Potential Therapeutics

Albert Leng,Manuj Shah,Syed Ameen Ahmad,Lavienraj Premraj,Karin Wildi,Gianluigi Li Bassi,Carlos A. Pardo,Alex Choi,Sung-Min Cho

DOI: https://doi.org/10.3390/cells12050816

IF: 6

2023-03-07

Cells

Abstract:The development of long-term symptoms of coronavirus disease 2019 (COVID-19) more than four weeks after primary infection, termed "long COVID" or post-acute sequela of COVID-19 (PASC), can implicate persistent neurological complications in up to one third of patients and present as fatigue, "brain fog", headaches, cognitive impairment, dysautonomia, neuropsychiatric symptoms, anosmia, hypogeusia, and peripheral neuropathy. Pathogenic mechanisms of these symptoms of long COVID remain largely unclear; however, several hypotheses implicate both nervous system and systemic pathogenic mechanisms such as SARS-CoV2 viral persistence and neuroinvasion, abnormal immunological response, autoimmunity, coagulopathies, and endotheliopathy. Outside of the CNS, SARS-CoV-2 can invade the support and stem cells of the olfactory epithelium leading to persistent alterations to olfactory function. SARS-CoV-2 infection may induce abnormalities in innate and adaptive immunity including monocyte expansion, T-cell exhaustion, and prolonged cytokine release, which may cause neuroinflammatory responses and microglia activation, white matter abnormalities, and microvascular changes. Additionally, microvascular clot formation can occlude capillaries and endotheliopathy, due to SARS-CoV-2 protease activity and complement activation, can contribute to hypoxic neuronal injury and blood–brain barrier dysfunction, respectively. Current therapeutics target pathological mechanisms by employing antivirals, decreasing inflammation, and promoting olfactory epithelium regeneration. Thus, from laboratory evidence and clinical trials in the literature, we sought to synthesize the pathophysiological pathways underlying neurological symptoms of long COVID and potential therapeutics.

cell biology
Persistent SARS-CoV-2 Infection, EBV, HHV-6 and Other Factors May Contribute to Inflammation and Autoimmunity in Long COVID

Aristo Vojdani,Elroy Vojdani,Evan Saidara,Michael Maes

DOI: https://doi.org/10.3390/v15020400

2023-01-31

Viruses

Abstract:A novel syndrome called long-haul COVID or long COVID is increasingly recognized in a significant percentage of individuals within a few months after infection with SARS-CoV-2. This disorder is characterized by a wide range of persisting, returning or even new but related symptoms that involve different tissues and organs, including respiratory, cardiac, vascular, gastrointestinal, musculo-skeletal, neurological, endocrine and systemic. Some overlapping symptomatologies exist between long COVID and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Very much like with long ME/CFS, infections with herpes family viruses, immune dysregulation, and the persistence of inflammation have been reported as the most common pattern for the development of long COVID. This review describes several factors and determinants of long COVID that have been proposed, elaborating mainly on viral persistence, reactivation of latent viruses such as Epstein–Barr virus and human herpesvirus 6 which are also associated with the pathology of ME/CFS, viral superantigen activation of the immune system, disturbance in the gut microbiome, and multiple tissue damage and autoimmunity. Based on these factors, we propose diagnostic strategies such as the measurement of IgG and IgM antibodies against SARS-CoV-2, EBV, HHV-6, viral superantigens, gut microbiota, and biomarkers of autoimmunity to better understand and manage this multi-factorial disorder that continues to affect millions of people in the world.

virology
Blood Biomarkers of Long COVID: A Systematic Review

Callum Thomas,Mark A Faghy,Corinna Chidley,Bethan E Phillips,Thomas Bewick,Ruth E Ashton

DOI: https://doi.org/10.1007/s40291-024-00731-z

Abstract:Background: Long coronavirus disease (COVID; LC) affects millions of people worldwide. The exact mechanisms which result in a broad, undulating and detrimental symptom profile remain unknown. Blood biomarkers associated with LC have been described; however, consensus on these remains elusive, in part due to a lack of continuity between studies on a universally accepted definition of LC. This systematic review aimed to consolidate current knowledge of blood biomarkers associated with the prevalence of LC on the basis of the World Health Organisation (WHO) clinical definition of this condition. Eligibility criteria for selecting studies: Observational, cross-sectional, and randomised control studies published in the English language that studied blood biomarkers associated with the WHO definition of LC. All studies included participants who were ≥ 18 years old and group sizes ≥ 10 participants, and were compared against a control group without any known co-morbidities. Methods: A systematic literature search was conducted according to Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines and prospectively registered on Prospero (ID: CRD42022373121). The Cochrane, Embase, PubMed and Web of Science databases were searched from inception to January 2024. Search results were gathered using Rayyan software and data extracted using Microsoft Excel. The reporting recommendations for tumour markers prognostic studies (REMARK) questionnaire was used to assess the quality of the included studies. Results: A total of 45 observational and one interventional study comprising 4415 participants were included in this review which identified 525 blood biomarkers thought to be associated with LC. Three blood biomarker subtypes were associated with the development of LC: (1) immunological and inflammatory dysfunction, (2) endothelial/vascular dysfunction and (3) metabolic and clotting abnormalities. Discussion and conclusions: Our data are consistent with previous findings; however, no single biomarker was sufficiently associated with LC prevalence and instead a profile of biomarkers across various physiological systems may be more clinically useful. In all, 196 studies were excluded due to a lack of an adequately healthy comparator group and/or failure to meet the WHO LC definition. This demonstrates a need for further research incorporating a universal LC definition across all disease severity groups and symptom profiles, and longitudinal data reflecting the relapsing and remitting nature of this condition. Further investigation into blood biomarkers of LC, including clear reporting of healthy comparator groups and the investigation of acute and chronic biomarker changes, within the context of medical practice, may support the development of curative/restorative approaches.
[How much confidence may be placed in the biological diagnosis of pregnancy?].

F. Baron,M. Lemaire,Y. Michiels

1962-08-01

Abstract:
Viral persistence, reactivation, and mechanisms of long COVID

Benjamin Chen,Boris Julg,Sindhu Mohandas,Steven B Bradfute

DOI: https://doi.org/10.7554/eLife.86015

IF: 7.7

2023-05-05

eLife

Abstract:The COVID-19 global pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has infected hundreds of millions of individuals. Following COVID-19 infection, a subset can develop a wide range of chronic symptoms affecting diverse organ systems referred to as post-acute sequelae of SARS-CoV-2 infection (PASC), also known as long COVID. A National Institutes of Health-sponsored initiative, RECOVER: Researching COVID to Enhance Recovery, has sought to understand the basis of long COVID in a large cohort. Given the range of symptoms that occur in long COVID, the mechanisms that may underlie these diverse symptoms may also be diverse. In this review, we focus on the emerging literature supporting the role(s) that viral persistence or reactivation of viruses may play in PASC. Persistence of SARS-CoV-2 RNA or antigens is reported in some organs, yet the mechanism by which they do so and how they may be associated with pathogenic immune responses is unclear. Understanding the mechanisms of persistence of RNA, antigen or other reactivated viruses and how they may relate to specific inflammatory responses that drive symptoms of PASC may provide a rationale for treatment.

biology
Systems-Level Immunomonitoring from Acute to Recovery Phase of Severe COVID-19

Lucie Rodriguez,Pirkka T. Pekkarinen,Tadepally Lakshmikanth,Ziyang Tan,Camila Rosat Consiglio,Christian Pou,Yang Chen,Constantin Habimana Mugabo,Ngoc Anh Nguyen,Kirsten Nowlan,Tomas Strandin,Lev Levanov,Jaromir Mikes,Jun Wang,Anu Kantele,Jussi Hepojoki,Olli Vapalahti,Santtu Heinonen,Eliisa Kekalainen,Petter Brodin

DOI: https://doi.org/10.1016/j.xcrm.2020.100078

IF: 16.988

2020-01-01

Cell Reports Medicine

Abstract:Severe disease of SARS-CoV-2 is characterized by vigorous inflammatory responses in the lung, often with a sudden onset after 5-7 days of stable disease. Efforts tomodulate this hyperinflammation and the associated acute respiratory distress syndrome rely on the unraveling of the immune cell interactions and cytokines that drive such responses. Given that every patient is captured at different stages of infection, longitudinal monitoring of the immune response is critical and systems-level analyses are required to capture cellular interactions. Here, we report on a systems-level blood immunomonitoring study of 37 adult patients diagnosed with COVID-19 and followed with up to 14 blood samples from acute to recovery phases of the disease. We describe an IFNg-eosinophil axis activated before lung hyperinflammation and changes in cell-cell co-regulation during different stages of the disease. We also map an immune trajectory during recovery that is shared among patients with severe COVID-19.
Sex differences and immune correlates of Long COVID development, persistence, and resolution

Rebecca E Hamlin,Shaun M Pienkos,Leslie Chan,Mikayla A Stabile,Kassandra Pinedo,Mallika Rao,Philip Grant,Hector Bonilla,Marisa Holubar,Upinder Singh,Karen B Jacobson,Prasanna Jagannathan,Yvonne Maldonado,Susan P Holmes,Aruna Subramanian,Catherine A Blish

DOI: https://doi.org/10.1101/2024.06.18.599612

2024-06-19

Abstract:Sex differences have been observed in acute COVID-19 and Long COVID (LC) outcomes, with greater disease severity and mortality during acute infection in males and a greater proportion of females developing LC. We hypothesized that sex-specific immune dysregulation contributes to the pathogenesis of LC. To investigate the immunologic underpinnings of LC development and persistence, we used single-cell transcriptomics, single-cell proteomics, and plasma proteomics on blood samples obtained during acute SARS-CoV-2 infection and at 3 and 12 months post-infection in a cohort of 45 patients who either developed LC or recovered. Several sex-specific immune pathways were associated with LC. Specifically, males who would develop LC at 3 months had widespread increases in signaling during acute infection in proliferating NK cells. Females who would develop LC demonstrated increased expression of , an RNA gene implicated in autoimmunity, and increased signaling in monocytes at 12 months post infection. Several immune features of LC were also conserved across sexes. Both males and females with LC had reduced co-stimulatory signaling from monocytes and broad upregulation of transcription factors. In both sexes, those with persistent LC demonstrated increased LAG3, a marker of T cell exhaustion, reduced transcription factor expression across lymphocyte subsets, and elevated intracellular IL-4 levels in T cell subsets, suggesting that ETS1 alterations may drive an aberrantly elevated Th2-like response in LC. Altogether, this study describes multiple innate and adaptive immune correlates of LC, some of which differ by sex, and offers insights toward the pursuit of tailored therapeutics.

Immunology
Long covid—mechanisms, risk factors, and management

Harry Crook,Sanara Raza,Joseph Nowell,Megan Young,Paul Edison

DOI: https://doi.org/10.1136/bmj.n1648

2021-07-26

BMJ

Abstract:Abstract Since its emergence in Wuhan, China, covid-19 has spread and had a profound effect on the lives and health of people around the globe. As of 4 July 2021, more than 183 million confirmed cases of covid-19 had been recorded worldwide, and 3.97 million deaths. Recent evidence has shown that a range of persistent symptoms can remain long after the acute SARS-CoV-2 infection, and this condition is now coined long covid by recognized research institutes. Studies have shown that long covid can affect the whole spectrum of people with covid-19, from those with very mild acute disease to the most severe forms. Like acute covid-19, long covid can involve multiple organs and can affect many systems including, but not limited to, the respiratory, cardiovascular, neurological, gastrointestinal, and musculoskeletal systems. The symptoms of long covid include fatigue, dyspnea, cardiac abnormalities, cognitive impairment, sleep disturbances, symptoms of post-traumatic stress disorder, muscle pain, concentration problems, and headache. This review summarizes studies of the long term effects of covid-19 in hospitalized and non-hospitalized patients and describes the persistent symptoms they endure. Risk factors for acute covid-19 and long covid and possible therapeutic options are also discussed.
Gut Microbiome Signatures During Acute Infection Predict Long COVID

Isin Yagmur Comba,Ruben T Mars,Lu Yang,Mitchell Dumais,Jun Y Chen,Trena M Van Gorp,Jonathan J. Harrington,Jason Paul Sinnwell,Stephen Johnson,La Rinda Holland,Adam K Khan,Efrem Lim,Christopher Aakre,Arjun Athreya,Georg K Gerber,John C. O'Horo,Konstantinos Lazaridis,Purna C Kashyap

DOI: https://doi.org/10.1101/2024.12.10.626852

2024-12-11

Abstract:Long COVID (LC), manifests in 10-30% of non-hospitalized individuals post-SARS-CoV-2 infection leading to significant morbidity. The predictive role of gut microbiome composition during acute infection in the development of LC is not well understood, partly due to the heterogeneous nature of disease. We conducted a longitudinal study of 799 outpatients tested for SARS-CoV-2 (380 positive, 419 negative) and found that individuals who later developed LC harbored distinct gut microbiome compositions during acute infection, compared with both SARS-CoV-positive individuals who did not develop LC and negative controls with similar symptomatology. However, the temporal changes in gut microbiome composition between the infectious (0-1 month) and post-infectious (1-2 months) phases was not different between study groups. Using machine learning, we showed that microbiome composition alone more accurately predicted LC than clinical variables. Including clinical data only marginally enhanced this prediction, suggesting that microbiome profiles during acute infection may reflect underlying health status and immune responses thus, help predicting individuals at risk for LC. Finally, we identified four LC symptom clusters, with gastrointestinal and fatigue-only groups most strongly linked to gut microbiome alterations.

Genomics
Unraveling the enigma of long COVID: novel aspects in pathogenesis, diagnosis, and treatment protocols

Abdul Mannan Baig,Sandy Rosko,Beate Jaeger,Joachim Gerlach,Hans Rausch

DOI: https://doi.org/10.1007/s10787-024-01483-2

2024-05-22

Inflammopharmacology

Abstract:Long COVID, now unmistakably identified as a syndromic entity encompassing a complex spectrum of symptoms, demands immediate resolution of its elusive pathogenic underpinnings. The intricate interplay of diverse factors presents a complex puzzle, difficult to resolve, and thus poses a substantial challenge. As instances of long COVID manifest by repeated infections of SARS-CoV-2 and genetic predisposition, a detailed understanding in this regard is needed. This endeavor is a comprehensive exploration and analysis of the cascading pathogenetic events driven by viral persistence and replication. Beyond its morbidity, long COVID, more disabling than fatal, exacts one of the most substantial tolls on public health in contemporary times, with the potential to cripple national economies. The paper introduces a unified theory of long COVID, detailing a novel pathophysiological framework that interlinks persistent SARS-CoV-2 infection, autoimmunity, and systemic vascular pathology. We posit a model where viral reservoirs, immune dysregulation, and genetic predispositions converge to perpetuate disease. It challenges prevailing hypotheses with new evidence, suggesting innovative diagnostic and therapeutic approaches. The paper aims to shift the paradigm in long COVID research by providing an integrative perspective that encapsulates the multifaceted nature of the condition. We explain the immunological mechanisms, hypercoagulability states, and viral reservoirs in the skull that feed NeuroCOVID in patients with long COVID. Also, this study hints toward a patient approach and how to prioritize treatment sequences in long COVID patients in hospitals and clinics.

immunology,toxicology

Optimal Gossip in Store-and-Forward Noncombining 2-D Tori

Long COVID manifests with T cell dysregulation, inflammation, and an uncoordinated adaptive immune response to SARS-CoV-2

Long COVID manifests with T cell dysregulation, inflammation and an uncoordinated adaptive immune response to SARS-CoV-2

Distinguishing features of Long COVID identified through immune profiling

The effect of bending radius on V-I characteristics of mono- and multicored BiPb-2223 tapes with and without Ag additions

The Central Role of Low-Grade Inflammation and Multisystem Involvement

A Mixed Method Systematic Review

Pathophysiological, immunological, and inflammatory features of long COVID

Immune Mechanisms Underpinning Long COVID: Collegium Internationale Allergologicum Update 2024

A review of cytokine-based pathophysiology of Long COVID symptoms

Metabolomic and immune alterations in long COVID patients with chronic fatigue syndrome

Pathogenesis Underlying Neurological Manifestations of Long COVID Syndrome and Potential Therapeutics

Persistent SARS-CoV-2 Infection, EBV, HHV-6 and Other Factors May Contribute to Inflammation and Autoimmunity in Long COVID

Blood Biomarkers of Long COVID: A Systematic Review

[How much confidence may be placed in the biological diagnosis of pregnancy?].

Viral persistence, reactivation, and mechanisms of long COVID

Systems-Level Immunomonitoring from Acute to Recovery Phase of Severe COVID-19

Sex differences and immune correlates of Long COVID development, persistence, and resolution

Long covid—mechanisms, risk factors, and management

Gut Microbiome Signatures During Acute Infection Predict Long COVID

Unraveling the enigma of long COVID: novel aspects in pathogenesis, diagnosis, and treatment protocols